ArticleMolecules (Basel, Switzerland)2021

A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights.

Mohammad M Al-Sanea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.